114 related articles for article (PubMed ID: 8089500)
1. Rapamycin inhibits production of cytotoxic but not noncytotoxic antibodies and preferentially activates T helper 2 cells that mediate long-term survival of heart allografts in rats.
Ferraresso M; Tian L; Ghobrial R; Stepkowski SM; Kahan BD
J Immunol; 1994 Oct; 153(7):3307-18. PubMed ID: 8089500
[TBL] [Abstract][Full Text] [Related]
2. Kinetics of in vitro immune responses of T and B cells during tolerance induction by sirolimus.
Ghobrial R; Karczewski M; Ferraresso M; Tian L; Stepkowski SM; Kahan BD
Ann Transplant; 1996; 1(4):22-9. PubMed ID: 9869901
[TBL] [Abstract][Full Text] [Related]
3. The mechanism of unresponsiveness to allografts induced by rapamycin and rapamycin/cyclosporine treatment in rats.
Ferraresso M; Ghobrial R; Stepkowski SM; Kahan BD
Transplantation; 1993 Apr; 55(4):888-94. PubMed ID: 8475565
[TBL] [Abstract][Full Text] [Related]
4. Selective immunosuppression with anti-interleukin 2 receptor-targeted therapy: helper and suppressor cell activity in rat recipients of cardiac allografts.
Kupiec-Weglinski JW; Padberg W; Uhteg LC; Ma L; Lord RH; Araneda D; Strom TB; Diamantstein T; Tilney NL
Eur J Immunol; 1987 Mar; 17(3):313-9. PubMed ID: 2952511
[TBL] [Abstract][Full Text] [Related]
5. Anti-TNF antibody modulates cytokine and MHC expression in cardiac allografts.
Wei RQ; Schwartz CF; Lin H; Chen GH; Bolling SF
J Surg Res; 1999 Feb; 81(2):123-8. PubMed ID: 9927530
[TBL] [Abstract][Full Text] [Related]
6. Rapamycin treatment depresses intragraft expression of KC/MIP-2, granzyme B, and IFN-gamma in rat recipients of cardiac allografts.
Wieder KJ; Hancock WW; Schmidbauer G; Corpier CL; Wieder I; Kobzik L; Strom TB; Kupiec-Weglinski JW
J Immunol; 1993 Jul; 151(2):1158-66. PubMed ID: 8335897
[TBL] [Abstract][Full Text] [Related]
7. Cytokine and alloantibody networks in long term cardiac allografts in rat recipients treated with rapamycin.
Wasowska B; Wieder KJ; Hancock WW; Zheng XX; Berse B; Binder J; Strom TB; Kupiec-Weglinski JW
J Immunol; 1996 Jan; 156(1):395-404. PubMed ID: 8598490
[TBL] [Abstract][Full Text] [Related]
8. CD4 mAb therapy modulates alloantibody production and intracardiac graft deposition in association with selective inhibition of Th1 lymphokines.
Kupiec-Weglinski JW; Wasowska B; Papp I; Schmidbauer G; Sayegh MH; Baldwin WM; Wieder KJ; Hancock WW
J Immunol; 1993 Nov; 151(9):5053-61. PubMed ID: 8409456
[TBL] [Abstract][Full Text] [Related]
9. A combination of anergic cells' adoptive transfer and rapamycin therapy prolongs cardiac allograft survival in mice.
Cai Y; Tang XD; Zhou PJ
Scand J Immunol; 2005 Mar; 61(3):266-73. PubMed ID: 15787744
[TBL] [Abstract][Full Text] [Related]
10. Evidence that rapamycin rescue therapy delays rejection of major (MHC) plus minor (non-MHC) histoincompatible heart allografts in rats.
Wang ME; Stepkowski SM; Ferraresso M; Kahan BD
Transplantation; 1992 Oct; 54(4):704-9. PubMed ID: 1412762
[TBL] [Abstract][Full Text] [Related]
11. Rapamycin inhibits the generation of graft-versus-host disease- and graft-versus-leukemia-causing T cells by interfering with the production of Th1 or Th1 cytotoxic cytokines.
Blazar BR; Taylor PA; Panoskaltsis-Mortari A; Vallera DA
J Immunol; 1998 Jun; 160(11):5355-65. PubMed ID: 9605135
[TBL] [Abstract][Full Text] [Related]
12. Reversal of ongoing heart, kidney, and pancreas allograft rejection and suppression of accelerated heart allograft rejection in the rat by rapamycin.
Chen H; Wu J; Xu D; Luo H; Daloze PM
Transplantation; 1993 Sep; 56(3):661-6. PubMed ID: 8212164
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of host-versus-graft and graft-versus-host responses after small bowel transplantation in rats by rapamycin.
Stepkowski SM; Chen HF; Wang ME; Daloze P; Kahan BD
Transplantation; 1992 Feb; 53(2):258-64. PubMed ID: 1738917
[TBL] [Abstract][Full Text] [Related]
14. Persistent infiltration of CD45RC- CD4+ T cells, Th2-like effector cells, in prolonging hepatic allografts in rats pretreated with a donor-specific blood transfusion.
Miyanari N; Yamaguchi Y; Matsuno K; Tominaga A; Goto M; Ichiguchi O; Mori K; Ogawa M
Hepatology; 1997 Apr; 25(4):1008-13. PubMed ID: 9096612
[TBL] [Abstract][Full Text] [Related]
15. Rapamycin-conditioned, alloantigen-pulsed dendritic cells promote indefinite survival of vascularized skin allografts in association with T regulatory cell expansion.
Horibe EK; Sacks J; Unadkat J; Raimondi G; Wang Z; Ikeguchi R; Marsteller D; Ferreira LM; Thomson AW; Lee WP; Feili-Hariri M
Transpl Immunol; 2008 Feb; 18(4):307-18. PubMed ID: 18158116
[TBL] [Abstract][Full Text] [Related]
16. Effects of interleukin-12p40 gene transfer on rat corneal allograft survival.
Ritter T; Yang J; Dannowski H; Vogt K; Volk HD; Pleyer U
Transpl Immunol; 2007 Nov; 18(2):101-7. PubMed ID: 18005852
[TBL] [Abstract][Full Text] [Related]
17. Allogeneic heart transplantation activates alloreactive NK cells.
Petersson E; Ostraat O; Ekberg H; Hansson J; Simanaitis M; Brodin T; Dohlsten M; Hedlund G
Cell Immunol; 1997 Jan; 175(1):25-32. PubMed ID: 9015185
[TBL] [Abstract][Full Text] [Related]
18. Anti-CD4 monoclonal antibody-induced tolerance to MHC-incompatible cardiac allografts maintained by CD4+ suppressor T cells that are not dependent upon IL-4.
Hall BM; Fava L; Chen J; Plain KM; Boyd RA; Spicer ST; Berger MF
J Immunol; 1998 Nov; 161(10):5147-56. PubMed ID: 9820484
[TBL] [Abstract][Full Text] [Related]
19. Anti-CD25 monoclonal antibody modulates cytokine expression and prolongs allografts survival in rats cardiac transplantation.
Xia J; Jiang X; Huang Y; Zhang K; Xiao S; Yang C
Chin Med J (Engl); 2003 Mar; 116(3):432-5. PubMed ID: 12781053
[TBL] [Abstract][Full Text] [Related]
20. Induction of tolerance to skin allografts by intrathymic injection of donor splenocytes. Effect of donor-recipient strain combination and supplemental rapamycin.
Dono K; Maki T; Wood ML; Monaco AP
Transplantation; 1995 Dec; 60(11):1268-73. PubMed ID: 8525521
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
